Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from Metlife ( (MET) ).
On August 6, 2025, MetLife, Inc. released its second-quarter results for 2025, highlighting a net income of $698 million and adjusted earnings of $1.4 billion. Despite a decline in adjusted earnings due to less favorable underwriting and lower investment margins, the company saw revenue growth driven by higher sales in Asia, Latin America, and EMEA. MetLife continued to execute its New Frontier strategy, focusing on strategic transactions to accelerate growth in asset management and retirement platforms, while managing expenses and returning approximately $900 million to shareholders.
The most recent analyst rating on (MET) stock is a Buy with a $93.00 price target. To see the full list of analyst forecasts on Metlife stock, see the MET Stock Forecast page.
Spark’s Take on MET Stock
According to Spark, TipRanks’ AI Analyst, MET is a Outperform.
Metlife demonstrates strong financial performance and effective cash flow management, which are key drivers of its solid stock score. While technical analysis indicates potential bearish trends, the company’s attractive valuation and positive earnings call sentiment provide a balanced outlook. Corporate events further support strategic growth, making Metlife a compelling investment in the life insurance industry.
To see Spark’s full report on MET stock, click here.
More about Metlife
MetLife, Inc. operates in the insurance industry, providing a range of insurance products and services, with a focus on life insurance, annuities, employee benefits, and asset management. The company has a significant presence in international markets, including Asia, Latin America, and EMEA, leveraging its market-leading positions to drive growth.
Average Trading Volume: 2,902,314
Technical Sentiment Signal: Buy
Current Market Cap: $50.27B
See more insights into MET stock on TipRanks’ Stock Analysis page.